Loading
Cases by country, the UK and NHS pathway and other country lenses, and the expert centres with trials on record.
No country-level case numbers. This cancer is not mapped to a GLOBOCAN site.
| United Kingdom | none recorded | 0 | 1,030 | 18,019 | #7 | ||
Baltimore · cancer center | United States | 0 | 2,962 | 42,161 | #10 | ||
Melbourne · cancer center | Australia | none recorded | 1 | 1,554 | 24,520 | #14 | |
Stanford · university | United States | 0 | 3,016 | 50,896 | #30 | ||
Sydney · consortium | Australia | none recorded | 1 | 3 | 3 | - | |
Essen · cancer center | Germany | none recorded | 1 | not matched | - | - | |
Dallas, TX · cancer center | United States | 0 | 1,744 | 19,757 | - | ||
Utrecht · cancer center | Netherlands | none recorded | 0 | 1,422 | 20,323 | - | |
Rozzano (Milan) · hospital | Italy | none recorded | 0 | 1,031 | 10,720 | - | |
Jinan · cancer center | China | none recorded | 0 | 920 | 7,804 | - | |
Freiburg im Breisgau · cancer center | Germany | none recorded | 0 | 746 | 6,165 | - | |
Ramat Gan · hospital | Israel | none recorded | 0 | 715 | 9,094 | - | |
London · hospital Programme: Prostate and urology | United Kingdom | none recorded | 0 | 693 | 7,168 | - | |
Düsseldorf · hospital | Germany | none recorded | 0 | 686 | 7,181 | - | |
| United Kingdom | none recorded | 0 | 637 | 10,594 | none recorded | - |
These are the things we can measure; they are not a ranking of quality. Each column is a field on the institution record or a count over what OnCo has linked; a centre that treats many patients with Metastatic castration-resistant prostate cancer but is thinly recorded here will look small.
Not known: OnCo holds no case-volume or outcome figures for centres, so none are shown. Where a national audit or registry publishes them, the centre's page links to it. Default order: Newsweek rank, then trials for this cancer, then research output.